RLAY vs USB · rev $10.0M vs P/E 12, rev $28.66B
Relay Therapeutics Inc (RLAY) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
Relay Therapeutics Inc (RLAY) is a biotechnology company listed on NASDAQ.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported RLAY revenue for 2024-12-31 was $10.0M. Net income was -$337.7M. Revenue was down 60.8% from 2023-12-31 to 2024-12-31. RLAY currently screens at market cap $3.39B.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
RLAY currently screens at market cap $3.39B. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the RLAY and USB stock pages for the full models.
Not investment advice.